[Corrigendum] MicroRNA‐122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma &lt;i&gt;in vitro&lt;/i&gt;. Here, AKT1 is linked to nasopharyngeal carcinoma.